Biogen International Gmbh, Biogen Ma Inc. v. Amneal Pharmaceuticals LLC, Alkem Laboratories Ltd., Hetero USA Inc., Cipla Limited,…

N OTE: This order is nonprecedential.
United States Court of Appeals
for the Federal Circuit
______________________
BIOGEN INTERNATIONAL GMBH,
BIOGEN MA INC.,
Plaintiffs-Appellants
v.
AMNEAL PHARMACEUTICALS LLC, ALKEM
LABORATORIES LTD., HETERO USA INC., CIPLA
LIMITED, CIPLA USA INC., HETERO LABS
LIMITED, HETERO LABS LIMITED UNIT-III,
LUPIN ATLANTIS HOLDINGS SA, MSN
LABORATORIES PRIVATE LTD., MSN
PHARMACEUTICALS INC., PHARMATHEN S.A.,
PRINSTON PHARMACEUTICAL INC., S&B
PHARMA, INC., SANDOZ INC., SHILPA MEDICARE
LIMITED, SUN PHARMACEUTICAL INDUSTRIES,
INC., SUN PHARMA GLOBAL FZE, SUN
PHARMACEUTICAL INDUSTRIES LIMITED,
ZYDUS PHARMACEUTICALS (USA) INC., TWI
PHARMACEUTICALS INC., TWI
PHARMACEUTICALS USA, INC.,
Defendants-Appellees
ACCORD HEALTHCARE INC., GRAVITI
PHARMACEUTICALS INC., GRAVITI
PHARMACEUTICALS PVT. LTD., IMPAX
LABORATORIES LLC, MACLEODS PHARMA USA,
INC., MACLEODS PHARMACEUTICALS LTD.,
SLAYBACK PHARMA LLC, SLAYBACK PHARMA
INDIA LLP, TORRENT PHARMA INC., TORRENT
Case: 21-1078 Document: 94 Page: 1 Filed: 10/31/2022

-- 1 of 3 --

BIOGEN INTERNATIONAL GMBH v. AMNEAL
PHARMACEUTICALS LLC
2
PHARMACEUTICALS LTD., WINDLAS
HEALTHCARE PVT. LTD.,
Defendants
______________________
2021-1078, 2021-1084, 2021-1086, 2021-1087, 2021-1088,
2021-1090, 2021-1091, 2021-1092, 2021-1093, 2021-1094,
2021-1095, 2021-1096, 2021-1097, 2021-1098, 2021-1441
______________________
Appeals from the United States District Court for the
District of Delaware in Nos. 1:17-cv-00823-MN, 1:17-cv-
00825-MN, 1:17-cv-00828-MN, 1:17-cv-00845-MN, 1:17-cv-
00846-MN, 1:17-cv-00847-MN, 1:17-cv-00850-MN, 1:17-cv-
00851-MN, 1:17-cv-00853-MN, 1:17-cv-00855-MN, 1:17-cv-
00856-MN, 1:17-cv-00872-MN, 1:17-cv-00874-MN, 1:17-cv-
00954-MN, and 1:20-cv-01159-MN, Judge Maryellen
Noreika.
______________________
ON MOTION
______________________
O R D E R
Upon consideration of appellants’ unopposed motion to
voluntarily dismiss the above-captioned consolidated ap-
peals pursuant to Federal Rule of Appellate Procedure
42(b) with each party to bear its own costs upon dismissal,
I T I S O RDERED T HAT :
(1) The motion is granted. The above-captioned ap-
peals are dismissed.
(2) Any other pending motion is denied as moot.
Case: 21-1078 Document: 94 Page: 2 Filed: 10/31/2022

-- 2 of 3 --

BIOGEN INTERNATIONAL GMBH v. AMNEAL
PHARMACEUTICALS LLC
3
(3) Each side shall bear its own costs.
October 31, 2022
Date
F OR THE COURT
/s/ Peter R. Marksteiner
Peter R. Marksteiner
Clerk of Court
ISSUED AS A MANDATE: October 31, 2022
Case: 21-1078 Document: 94 Page: 3 Filed: 10/31/2022

-- 3 of 3 --